US 7354939
Pyrrole inhibitors of ERK protein kinase, synthesis thereof and intermediates thereto
granted A61PA61P1/04A61P1/16
Quick answer
US patent 7354939 (Pyrrole inhibitors of ERK protein kinase, synthesis thereof and intermediates thereto) held by Vertex Pharmaceuticals Incorporated expires Mon Apr 03 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Apr 08 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 03 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61P, A61P1/04, A61P1/16, A61P1/18, A61P15/00